申请人:YAMAMOTO Takashi
公开号:US20130041000A1
公开(公告)日:2013-02-14
Azole compounds represented by formula I:
wherein ring A is isoxazole and the like, R1 is a substituted or unsubstituted aryl group and the like, R2 is a hydrogen atom and the like, and R3 is a substituted or unsubstituted alkyl group and the like, and pharmaceutically acceptable salts thereof inhibit the physiological activity of lysophosphatidic acid (LPA), and are useful as for the prophylaxis or treatment of diseases in which inhibition of the physiological activity of LPA is useful for the prophylaxis or treatment thereof, such as diseases involving the LPA receptor.
公式I所代表的氮唑化合物,其中环A是异噁唑等,R1是取代或未取代的芳基基团等,R2是氢原子等,R3是取代或未取代的烷基基团等,以及其药学上可接受的盐,能够抑制溶血磷脂酸(LPA)的生理活性,可用于预防或治疗需要抑制LPA生理活性的疾病,例如涉及LPA受体的疾病。